Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 13/20 | 0.47 |
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.47 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.38 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.38 |
| ▸ | P4HB | P07237 | 1/20 | 0.36 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA3 | P07451 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA6 | P23280 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17816869 | 1.00 | LPL (0.47) | LPLLIPGPRMT5WDR77P4HB | |
| SCHEMBL17780741 | 0.98 | LPL (0.49) | LPLLIPGPRMT5WDR77P4HB | |
| SCHEMBL29603284 | 0.98 | LPL (0.49) | LPLLIPGPRMT5WDR77P4HB | |
| SCHEMBL29602682 | 0.98 | LPL (0.49) | LPLLIPGPRMT5WDR77P4HB | |
| SCHEMBL12181998 | 0.98 | LPL (0.49) | LPLLIPGPRMT5WDR77P4HB | |
| SCHEMBL23349135 | 0.94 | LPL (0.45) | LPLLIPGPRMT5WDR77P4HB | |
| SCHEMBL20222384 | 0.92 | LPL (0.41) | LPLLIPGPRMT5WDR77P4HB | |
| SCHEMBL19164440 | 0.91 | LPL (0.47) | LPLLIPGPRMT5WDR77P4HB | |
| SCHEMBL21380081 | 0.91 | LPL (0.47) | LPLLIPGPRMT5WDR77P4HB | |
| SCHEMBL17816719 | 0.91 | LPL (0.47) | LPLLIPGPRMT5WDR77P4HB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11183641-B2 | Composition for an organic electronic device and organic electronic device using the same | SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) | 2021-11-23 | — | — | US | disclosed |
| US-10312459-B2 | Compound and organic electronic device using the same | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2019-06-04 | — | — | US | disclosed |
| US-20170213978-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2017-07-27 | — | — | US | disclosed |
| US-20170213978-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2017-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11183641-B2 | Composition for an organic electronic device and organic electronic device using the same | ORC3, ZYX, ESR1 | LPL 3958/4885LIPG 2739/4885PRMT5 3302/4885 |
| US-20170213978-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | OR51E2, OR10J3, ESR1 | LPL 3885/4885LIPG 1415/4885PRMT5 2875/4885 |
| US-10312459-B2 | Compound and organic electronic device using the same | OR51E2, OR10J3, ESR1 | LPL 3885/4885LIPG 1415/4885PRMT5 2875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.